IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
1-Year Return
45.66%
This Quarter Return
+4.58%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$166M
AUM Growth
+$6.26M
(+3.9%)
Cap. Flow
+$2.91M
Cap. Flow
% of AUM
1.76%
Top 10 Holdings %
Top 10 Hldgs %
45.01%
Holding
82
New
12
Increased
11
Reduced
20
Closed
11
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$9.02M |
| 2 |
AbbVie
ABBV
|
$4.8M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$4.65M |
| 4 |
HCA Healthcare
HCA
|
$4.51M |
| 5 |
Tenet Healthcare
THC
|
$3.99M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
$8.04M |
| 2 |
Cigna
CI
|
$6.67M |
| 3 |
Merck
MRK
|
$3.33M |
| 4 |
Pfizer
PFE
|
$3.21M |
| 5 |
Incyte
INCY
|
$3.08M |
Sector Composition
| 1 | Healthcare | 87.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WMGI
26
DELISTED
Wright Medical Group Inc
WMGI
| $2.67M | 1.25% |
85,000
-15,000
| -15% | -$471K |
|
27
Teva Pharmaceuticals
TEVA
$21.7B
| $2.62M | 1.22% |
50,000
| – | – |
|
|
28
Cigna
CI
$81.5B
| $2.3M | 1.07% |
25,000
-72,500
| -74% | -$6.67M |
|
|
IPXL
29
DELISTED
Impax Laboratories, Inc.
IPXL
| $2.25M | 1.05% |
75,000
-70,000
| -48% | -$2.1M |
|
30
BioMarin Pharmaceuticals
BMRN
$11.1B
| $2.02M | 0.94% |
32,500
+7,500
| +30% | +$467K |
|
31
Esperion Therapeutics
ESPR
$540M
| $1.98M | 0.92% |
125,000
-10,000
| -7% | -$158K |
|
|
NVDQ
32
DELISTED
Novadaq Technologies Inc.
NVDQ
| $1.98M | 0.92% |
120,000
-55,000
| -31% | -$907K |
|
33
Ultragenyx Pharmaceutical
RARE
$3.09B
| $1.88M | 0.88% |
41,800
-13,200
| -24% | -$592K |
|
34
Puma Biotechnology
PBYI
$256M
| $1.82M | 0.85% |
27,500
-7,500
| -21% | -$495K |
|
35
Assertio
ASRT
$76.8M
| $1.74M | 0.81% |
31,250
+6,250
| +25% | +$348K |
|
|
NPSP
36
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $1.74M | 0.81% |
+52,500
| New | +$1.74M |
|
37
Vanda Pharmaceuticals
VNDA
$271M
| $1.62M | 0.75% |
100,000
| – | – |
|
|
TSRO
38
DELISTED
TESARO, Inc.
TSRO
| $1.56M | 0.73% |
50,000
| – | – |
|
|
AVNR
39
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $1.41M | 0.66% |
250,000
| – | – |
|
|
LUMO
40
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.33M | 0.62% |
+5,556
| New | +$1.33M |
|
|
DYAX
41
DELISTED
DYAX CORPORATION
DYAX
| $1.13M | 0.53% |
117,500
+17,500
| +18% | +$168K |
|
|
AKAO
42
DELISTED
Achaogen, Inc.
AKAO
| $1.05M | 0.49% |
75,000
+20,000
| +36% | +$279K |
|
|
EGLT
43
DELISTED
Egalet Corporation
EGLT
| $984K | 0.46% |
75,000
-25,000
| -25% | -$328K |
|
|
ETRM
44
DELISTED
EnteroMedics Inc.
ETRM
| $936K | 0.44% |
571
-524
| -48% | -$859K |
|
|
LJPC
45
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $918K | 0.43% |
100,000
-12,500
| -11% | -$115K |
|
|
SRNE
46
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $878K | 0.41% |
130,000
+80,000
| +160% | +$540K |
|
|
FLXN
47
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $674K | 0.31% |
50,000
-40,000
| -44% | -$539K |
|
48
Nuwellis
NUWE
$4.36M
| – | – |
0
| – | -$1.17M |
|
|
AVDL
49
Avadel Pharmaceuticals
AVDL
$1.5B
| $375K | 0.17% |
+25,000
| New | +$375K |
|
50
Savara
SVRA
$638M
| $315K | 0.15% |
7,143
| – | – |
|